Expectations for artificial intelligence’s use in pharma research typically skew heavily on ingredients which would be Rx-only, but firms looking at making additional drugs available OTC could have as much or more to gain.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?